SCAP and hepatocellular carcinoma: Xu and colleagues [50] demonstrated that disrupting the interaction between INSIGs and SCAP (due to activation of the AKT/PCK1 axis in hepatocellular carcinoma cells) leads to activation of SREBPs and, consequently, lipogenesis that in turn increases cell proliferation.